Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”
JOURNAL OF CLINICAL ONCOLOGY(2024)
Abstract
We sought to assess survival outcomes of patients with de novo metastatic breast cancer (dnMBC) who did not receive treatment irrespective of the reason. Adults with dnMBC were selected from the NCDB (2010–2016) and stratified based on receipt of treatment (treated = received at least one treatment and untreated = received no treatments). Overall survival (OS) was estimated using the Kaplan–Meier method, and groups were compared. Cox proportional hazards models were used to identify factors associated with OS. Of the 53,240 patients with dnMBC, 92.1
MoreTranslated text
Key words
Breast cancer,Metastatic,Stage IV,Outcomes,Survival
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined